Effects of Resveratrol Administration in Liver Injury Prevention as Induced by an Obesogenic Diet: Role of Ruminococcaceae
出版年份 2022 全文链接
标题
Effects of Resveratrol Administration in Liver Injury Prevention as Induced by an Obesogenic Diet: Role of Ruminococcaceae
作者
关键词
-
出版物
Biomedicines
Volume 10, Issue 8, Pages 1797
出版商
MDPI AG
发表日期
2022-07-27
DOI
10.3390/biomedicines10081797
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Polydextrose Alleviates Adipose Tissue Inflammation and Modulates the Gut Microbiota in High-Fat Diet-Fed Mice
- (2022) Qiuyue Hu et al. Frontiers in Pharmacology
- Gut microbiota-derived metabolites are novel targets for improving insulin resistance
- (2022) Rosana MC Bastos et al. World Journal of Diabetes
- Anti-Inflammatory Action and Mechanisms of Resveratrol
- (2021) Tiantian Meng et al. MOLECULES
- Resveratrol Improves Liver Steatosis and Insulin Resistance in Non-alcoholic Fatty Liver Disease in Association With the Gut Microbiota
- (2021) Fan Du et al. Frontiers in Microbiology
- Gut Microbiota Induced by Pterostilbene and Resveratrol in High-Fat-High-Fructose Fed Rats: Putative Role in Steatohepatitis Onset
- (2021) Iñaki Milton-Laskibar et al. Nutrients
- Targeting the gut microbiota with resveratrol: a demonstration of novel evidence for the management of hepatic steatosis
- (2020) Pan Wang et al. JOURNAL OF NUTRITIONAL BIOCHEMISTRY
- Using MicrobiomeAnalyst for comprehensive statistical, functional, and meta-analysis of microbiome data
- (2020) Jasmine Chong et al. Nature Protocols
- Effect of resveratrol on intestinal tight junction proteins and the gut microbiome in high-fat diet-fed insulin resistant mice
- (2020) Kaiting Chen et al. INTERNATIONAL JOURNAL OF FOOD SCIENCES AND NUTRITION
- Endogenous ethanol produced by intestinal bacteria induces mitochondrial dysfunction in nonalcoholic fatty liver disease
- (2020) Xiao Chen et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Phenotyping non‐alcoholic fatty liver disease by the gut microbiota: Ready for prime time?
- (2020) Münevver Demir et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders
- (2020) Judith Aron-Wisnewsky et al. Nature Reviews Gastroenterology & Hepatology
- Gut microbiota in human metabolic health and disease
- (2020) Yong Fan et al. NATURE REVIEWS MICROBIOLOGY
- The Gut Microbiota and Inflammation: An Overview
- (2020) Zahraa Al Bander et al. International Journal of Environmental Research and Public Health
- The Gut Microbiome and Individual-Specific Responses to Diet
- (2020) Avner Leshem et al. mSystems
- Gut microbiota: novel therapeutic target for nonalcoholic fatty liver disease
- (2019) Ki Tae Suk et al. Expert Review of Gastroenterology & Hepatology
- Resveratrol-induced gut microbiota reduces obesity in high-fat diet-fed mice
- (2019) Pan Wang et al. INTERNATIONAL JOURNAL OF OBESITY
- Effects of dietary fat on gut microbiota and faecal metabolites, and their relationship with cardiometabolic risk factors: a 6-month randomised controlled-feeding trial
- (2019) Yi Wan et al. GUT
- Resveratrol attenuates high-fat diet-induced non-alcoholic steatohepatitis by maintaining gut barrier integrity and inhibiting gut inflammation through regulation of the endocannabinoid system
- (2019) Mengting Chen et al. CLINICAL NUTRITION
- Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2
- (2019) Evan Bolyen et al. NATURE BIOTECHNOLOGY
- Deciphering the Anti-obesity Benefits of Resveratrol: The “Gut Microbiota-Adipose Tissue” Axis
- (2019) Liyuan Zhou et al. Frontiers in Endocrinology
- Gut Microbiota and Risk of Persistent Nonalcoholic Fatty Liver Diseases
- (2019) Han-Na Kim et al. Journal of Clinical Medicine
- Factors affecting the composition of the gut microbiota, and its modulation
- (2019) Nihal Hasan et al. PeerJ
- Distinct gut metagenomics and metaproteomics signatures in prediabetics and treatment-naïve type 2 diabetics
- (2019) Huanzi Zhong et al. EBioMedicine
- THE ROLE OF THE GUT MICROBIOTA IN LIVER DISEASE
- (2019) Somaya A. M. Albhaisi et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Beneficial Effects of Dietary Polyphenols on Gut Microbiota and Strategies to Improve Delivery Efficiency
- (2019) Amit Kumar Singh et al. Nutrients
- Gut Microbiota as a Therapeutic Target for Metabolic Disorders
- (2018) Hirofumi Okubo et al. CURRENT MEDICINAL CHEMISTRY
- Aberrant intestinal microbiota in individuals with prediabetes
- (2018) Kristine H. Allin et al. DIABETOLOGIA
- Resveratrol, Metabolic Syndrome, and Gut Microbiota
- (2018) Alice Chaplin et al. Nutrients
- Gut microbiota dysbiosis in patients with non-alcoholic fatty liver disease
- (2017) Feng Shen et al. Hepatobiliary & Pancreatic Diseases International
- Nonalcoholic Fatty Liver Disease and Insulin Resistance: New Insights and Potential New Treatments
- (2017) Hironori Kitade et al. Nutrients
- Microbiome Datasets Are Compositional: And This Is Not Optional
- (2017) Gregory B. Gloor et al. Frontiers in Microbiology
- Resveratrol and caloric restriction prevent hepatic steatosis by regulating SIRT1-autophagy pathway and alleviating endoplasmic reticulum stress in high-fat diet-fed rats
- (2017) Shibin Ding et al. PLoS One
- Effect of specific amino acids on hepatic lipid metabolism in fructose-induced non-alcoholic fatty liver disease
- (2016) Prasanthi Jegatheesan et al. CLINICAL NUTRITION
- The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)
- (2016) Elena Buzzetti et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- DADA2: High-resolution sample inference from Illumina amplicon data
- (2016) Benjamin J Callahan et al. NATURE METHODS
- Prevalence of and risk factors for non-alcoholic fatty liver disease in a Chinese population: An 8-year follow-up study
- (2016) Zhen-Ya Lu et al. WORLD JOURNAL OF GASTROENTEROLOGY
- The gut microbiome in health and in disease
- (2015) Andrew B. Shreiner et al. CURRENT OPINION IN GASTROENTEROLOGY
- Resveratrol improves insulin resistance, glucose and lipid metabolism in patients with non-alcoholic fatty liver disease: A randomized controlled trial
- (2015) Shihui Chen et al. DIGESTIVE AND LIVER DISEASE
- Dysbiosis gut microbiota associated with inflammation and impaired mucosal immune function in intestine of humans with non-alcoholic fatty liver disease
- (2015) Weiwei Jiang et al. Scientific Reports
- Resveratrol supplementation improves inflammatory biomarkers in patients with nonalcoholic fatty liver disease
- (2014) Forouzan Faghihzadeh et al. NUTRITION RESEARCH
- Understanding the role of gut microbiome in metabolic disease risk
- (2014) Yolanda Sanz et al. PEDIATRIC RESEARCH
- Impact of Polyphenols and Polyphenol-Rich Dietary Sources on Gut Microbiota Composition
- (2013) Usune Etxeberria et al. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
- Role of Dietary Polyphenols and Inflammatory Processes on Disease Progression Mediated by the Gut Microbiota
- (2013) J. Alfredo Martínez et al. REJUVENATION RESEARCH
- The SILVA ribosomal RNA gene database project: improved data processing and web-based tools
- (2012) Christian Quast et al. NUCLEIC ACIDS RESEARCH
- The impact of nutrition on the human microbiome
- (2012) Harry J Flint NUTRITION REVIEWS
- Bioavailability of resveratrol
- (2011) Thomas Walle Annals of the New York Academy of Sciences
- Effects of different doses of resveratrol on body fat and serum parameters in rats fed a hypercaloric diet
- (2010) M. T. Macarulla et al. JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY
- The role of the gut microbiota in nonalcoholic fatty liver disease
- (2010) Ahmed Abu-Shanab et al. Nature Reviews Gastroenterology & Hepatology
- Effect of 6-month nutritional intervention on non-alcoholic fatty liver disease
- (2009) Maria Cristina Elias et al. NUTRITION
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More